Description of the medicine: Sulfatonum (Sulfatonum)
A combined preparation containing, like bactrim, two active substances - sulfonamide preparation sulfamonomethoxine and a derivative of diaminopyrimidine - trimethoprim.
Available in tablets containing 0.25 g sulfamonomethoxin and 0.1 g trimethoprim. Tablets are white or white with a slightly yellowish tint.
The higher antibacterial activity of sulfamonomethoxin compared to sulfamethoxazole allows the use of sulfamonemetoxin in sulfatone in a lower dose than sulfamethoxazole in bactrim.
According to the mechanism of action, sulfatone is similar to bactrim. It is a broad-spectrum antimicrobial agent; in some cases, more effective than bactrim.
Sulfatone is used for acute and chronic bacterial infections, for the treatment of severe and moderate diseases; prescribed for adults and children with acute and chronic bronchitis, pneumonia (including abscessed and croupous), lung abscess, pleural empyema, local purulent infection of various localization, generalized forms of purulent infection (including sepsis), external and average otitis media, sinusitis , tonsillitis, pyelonephritis, cystitis, cholecystitis, cholangitis, dysentery and bacterial enterocolitis, erysipelas, meningococcal infection, gonorrhea, for the prevention of purulent complications after surgery.
Accepted in the form of tablets inside, regardless of the time of meal.
In the treatment of infections of the ear, throat, nose, upper respiratory tract, bronchopulmonary apparatus, urinary and urinary tract infections, local purulent infection, dysentery, bacterial enterocolitis, dysbiosis, and also for the prevention of infections after surgery, sulfatone is prescribed to adults on the 1st day of treatment according to 2 tablets (each 0.35 g) in the morning and evening (loading dose), in the following days - 1 tablet in the morning and evening (maintenance dose). The course of treatment is 5-14 days.
Patients with severe forms of purulent infection (lung abscess, pleural empyema), including those accompanied by a generalization of the process (sepsis, purulent-resorptive fever), with meningococcal infection, secondary bacterial meningitis, the drug is prescribed on the 1st day for 4 tablets in the morning and in the evening (loading dose), and in the following days - 2 tablets per reception in the morning and in the evening (maintenance dose). The course of treatment is 7-14 days.
With good tolerability of the drug, treatment of patients with severe infections can be extended up to 3 weeks.
According to indications, sulfatone can be prescribed together with broad-spectrum antibiotics.